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Abstract
Background: Cryptococcosis, a fatal fungal infection of the central nervous system, is one of the
major killers of AIDS patients and other immunocompromised hosts. The causative agent,
Cryptococcus neoformans, has a remarkable ability to 'hide' and proliferate within phagocytic cells of
the human immune system. This intracellular phase is thought to underlie the ability of the pathogen
to remain latent for long periods of time within infected individuals.
Results: We now report that Cryptococcus is able to undergo 'lateral transfer' between phagocytes,
moving directly from infected to uninfected macrophages. This novel process was observed in both
C. neoformans serotypes (A and D) and occurs in both immortalised cell lines and in primary human
macrophages. Lateral transfer is independent of the initial route of uptake, since both serum-
opsonised and antibody-opsonised C. neoformans are able to undergo direct cell-to-cell transfer.
Conclusion: We provide the first evidence for lateral transfer of a human fungal pathogen. This
rare event may occur repeatedly during latent cryptococcal infections, thereby allowing the
pathogen to remain concealed from the immune system and protecting it from exposure to
antifungal agents.
Background
Cryptococcus neoformans is an encapsulated basidiomycete
yeast that causes disseminating infections in immuno-
compromised hosts, especially those with AIDS. There are
two varieties of C. neoformans: C. neoformans var. neoform-
ans (Serotype D) and C. neoformans var. grubii (Serotype
A). Both are ubiquitous in the environment and can be
commonly isolated from avian excreta, soil and trees.
Infection is thought to begin with the inhalation of air-
borne spores and epidemiological evidence suggests that
exposure to Cryptococcus early in life can produce a pro-
longed, asymptomatic, latent infection [1]. Should an
infected individual later become immunocompromised,
the fungus can then spread from the lungs to the central
nervous system to cause meningoencephalitis, which is
uniformly fatal without rapid clinical intervention [2].
The mechanism by which C. neoformans achieves latency
and persistence prior to dissemination from its primary
site of infection in the lung remains poorly understood.
Recent data have revealed an important role for macro-
phages in this process. Firstly, C. neoformans shows a
remarkable ability to survive and proliferate within host
macrophages in vitro [3,4]. Secondly, live cryptococci can
be recovered from circulating monocytes in infected mice
[5]. Thirdly, recent studies by our group and others have
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within macrophages by a novel expulsive mechanism
[6,7]. After the expulsion, both the host macrophage and
the expelled C. neoformans appear morphologically nor-
mal and continue to proliferate, suggesting that this proc-
ess may represent an important mechanism by which
pathogens are able to escape from phagocytic cells with-
out triggering host cell death and thus inflammation.
These findings have led to the so-called "Trojan horse"
hypothesis on dissemination of C. neoformans, which pro-
poses that cryptococci are engulfed by phagocytic cells at
an early stage of infection and then trafficked by these
host cells into distal tissues without being exposed to the
full onslaught of the immune system [8,9]. However, it is
not known how cryptococci remain intracellular for pro-
longed periods prior to dissemination, given that the
period of latency far exceeds the natural lifespan of a host
macrophage.
Using timelapse microscopy, we now show that C. neofor-
mans is able to undergo 'lateral transfer' between phago-
cytes, during which the pathogen moves directly from an
infected cell to neighbouring uninfected cells. This mech-
anism may explain the ability of C. neoformans to remain
latent within the host during long periods of asympto-
matic persistence, as well as providing protection during
dissemination from primary sites of infection.
Results
We observed lateral transfer in both cultured murine J774
cells and human primary macrophage cells [see addi-
tional files 1 and 2]. During this process C. neoformans
cells contained within a membrane-bound compartment
of an infected macrophage are passed directly to a neigh-
bouring (uninfected) macrophage (Figure 1). Compared
to expulsion [6,7] and intracellular proliferation [4], lat-
eral transfer is a rare event since we observed only four
events of lateral transfer after monitoring 177 human pri-
mary macrophages with internalised cryptococci (Table
1). However, we are likely to underestimate the true rate
of lateral transfer, since experimental constraints mean
that we can only monitor infected cells for sixteen hours
after phagocytosis.
Like cryptococcal expulsion [6,7], lateral transfer is inde-
pendent of the initial route of uptake, since both serum-
opsonised and antibody-opsonised C. neoformans are
able to undergo direct cell-to-cell transfer (data not
shown). We have also observed lateral transfer in two C.
neoformans strains: JEC21 (Serotype D) and 125.91
(Serotype A), suggesting that it is not serotype dependent.
Lateral transfer is preceded by highly dynamic movement
of both the donor and recipient macrophage, which is
driven by the actin cytoskeleton. Imaging of over 300
macrophages treated with the actin depolymerising drug
cytochalasin D revealed no cases of lateral transfer, sug-
gesting that transfer is dependent either on actin dynamics
per se, or on actin-dependent host cell motility.
Lateral transfer is a very rapid process; transfer always
completes within ten minutes of the onset of cell mem-
brane fusion between the donor and recipient macro-
phage cells. Interestingly, three out of four lateral transfer
events observed in primary human cells were followed by
yeast expulsion, suggesting that the cryptococcal phago-
some may be in a special, highly fusogenic state. Alterna-
tively, it is possible that cryptococci that subsequently
undergo lateral transfer are initially internalized into an
atypical 'transfer-competent' compartment (rather than a
phagosome) although this seems unlikely given that inter-
nalized cryptococci have previously been shown to
acquire normal phagosome markers [7,10].
Discussion
In this study, we report a direct cell-to-cell spread mecha-
nism used by C. neoformans to travel between macrophage
cells. The molecular mechanism that drives lateral transfer
needs further investigation. It superficially resembles the
phenomenon of cryptococcal expulsion, since both phe-
nomena appear to be driven by rapid membrane fusion.
However, since lateral transfer is blocked by cytochalasin
D and cryptococcal expulsion is not [6,7], it appears that
there may be important mechanistic differences between
the two processes which may reflect a greater dependence
on host cell motility in the case of lateral transfer. Direct
cell-to-cell spread has been described for some pathogenic
bacteria, such as Listeria, Rickettsia and Shigella, and many
viruses (e.g. poxvirus). Most of these organisms undergo
direct cell-to-cell spread via polarised actin polymerisa-
tion, which generates force to propel them through the
cytoplasm of the infected cell and into uninfected neigh-
bouring cells [11-13]. However, the transmission of cryp-
tococci between cells is morphologically very different to
these other pathogens and is not preceded by directed
propulsion within the host cytoplasm, suggesting that the
underlying mechanism may be distinct.
Despite the low rate of lateral transfer observed in vitro, we
hypothesise that this process may have significant clinical
implications since it allows C. neoformans to remain intra-
cellular, thus avoiding immune recognition. Furthermore,
it allows the pathogen to move from weak to healthy
phagocytes, thus ensuring intracellular persistence of the
pathogen even if the host cell starts to die. Finally, infected
macrophage cells may travel widely throughout the host
circulatory and lymphatic systems, where they interact
intimately with one another and with other cell types
through transient contacts [12]. We speculate that inter-Page 2 of 5
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order to cross the blood-brain barrier by direct cell-to-cell
spread from adherent infected macrophages to microvas-
cular endothelial cells [14]. In fact, spreading from macro-
phages to other cell types during dissemination has been
demonstrated for other pathogens in vitro. For instance,
the Gram-positive bacterium Listeria monocytogenes can
infect neurons by cell-to-cell spread from adherent macro-
phages, a more efficient process than direct invasion of
neurons [15]. Intriguingly, cell-to-cell spread of bacteria
from adherent infected phagocytes to endothelial cells of
the central nervous system has also been reported [8,16]
and it will clearly be of great interest to investigate
whether a similar process may occur during cryptococco-
sis.
Conclusion
We report a new phenomenon, termed lateral transfer, by
which pathogenic yeast can be transmitted between host
cells. Lateral transfer of Cryptococcus is likely to be an
important step regulating phagocyte-facilitated latency
and dissemination. A better understanding of this process
will be of considerable importance in developing new
therapeutic strategies against cryptococcosis.
Methods
Yeast Strains and Growth Conditions
Cryptococcus neoformans strains JEC21 (Serotype D) and
125.91 (Serotype A, Tanzanian clinical isolate) were
grown overnight in YPG medium (1% yeast extract, 1%
peptone, and 2% glucose) with 50 μg/ml ampicillin at
25°C with shaking.
Cell Line and Culture Media
J774 cells were grown at 37°C in 5% CO2 in DMEM with
10% heat-inactivated FBS, 2 mM L-glutamine, 100 units/
ml penicillin, and 100 μg/ml streptomycin. The cell line
was used between five and 20 passages after thawing.
Human primary blood macrophage cells (PBMC) were
prepared as described previously [17] and resuspended at
6 × 106 cells/ml in RPMI 1640 medium containing 2%
pooled AB+ male human serum and 2 mM L-glutamine.
The PBMC were then seeded into 175 cm tissue-culture
flasks. Non-adherent cells were removed by extensive
washes with PBS, and adherent monocytes were incu-
bated overnight in RPMI medium + 5% human serum
supplemented with GM-CSF (100 IU/ml). After overnight
incubation, adherent cells were removed from flasks by
incubation on ice in pre-chilled PBS and cultured for 4–5
days in RPMI + 5% human serum and GM-CSF (100 IU/
ml). The cells were adjusted to 1 × 106 cells/ml and then
aliquoted into 3 cm plastic Petri dishes in 3 ml cultures.
The cell media was replenished on days 3 and 5 and
yielded adherent, confluent macrophage cultures at day 7.
Subsequently, the macrophages were activated with LPS
(1 μg/ml) and IFNγ (1000 IU/ml), which were added to
the culture dishes 24 hr prior to infection with C. neoform-
ans.
Phagocytosis Assay
J774 cells (6 × 105) were plated into a 35 mm tissue-cul-
ture-treated plate 16–24 hr before the assay. Shortly
before use, cells were incubated for 1 hr in serum-free
DMEM medium (Complete DMEM medium without
heat-inactivated FBS) containing 150 ng/ml PMA. Simi-
larly, the primary macrophage cells (which have been acti-
vated with LPS and IFNγ) were incubated for 1 hr in
serum-free DMEM medium.
At the same time, C. neoformans cells were washed three
times with phosphate-buffered saline (PBS) [pH 7.2] and
counted in a haemocytometer. For experiments using
J774, C. neoformans was incubated with 10 μg/ml of the
monoclonal antibody 18B7 (a kind gift of Arturo
Casadevall) at 37°C for 1 hr. 20% fresh human serum was
used to opsonise C. neoformans for experiments with
human primary macrophages.
To commence the assay, the medium containing PMA was
removed and replaced by normal serum-free medium
containing C. neoformans at a ratio of ten yeast cells per
macrophage. We allowed phagocytosis to proceed for 2 hr
at 37°C in a 5% CO2 atmosphere. We then removed non-
internalized yeast cells by three successive washes with
serum-free medium and maintained cells in serum-free
medium with 25 mM HEPES for time-lapse imaging.
Image Capture and Analysis
Cells were maintained at 37°C with a temperature-con-
trolled chamber (Solent Scientific) and imaged on a Zeiss
Axiovert 100 inverted microscope with a 32× dry objective
Table 1: The rate of expulsion and lateral transfer events recorded for JEC21 (Serotype D) in primary human macrophage cells
Primary human macrophage cells
Total number of macrophages observed 661
Macrophages with internalized yeast 177 (26.8%)
Occurrence of cryptococcal expulsion 47 (26.6%)
Occurrence of lateral transfer 4 (2.3%)Page 3 of 5
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Lateral transfer of JEC21 (white arrow) from infected (donor, rectangle) to uninfected (recipient, oval) human primary cellsFigure 1
Lateral transfer of JEC21 (white arrow) from infected (donor, rectangle) to uninfected (recipient, oval) human 
primary cells. (A to E) The donor cell moves underneath the recipient cell and after 85 min, the recipient macrophage con-
tacts the cryptococcal containing compartment. (F to I) About 160 min after the onset of filming, membrane fusion starts to 
occur at the contact point of the two cells and initiates lateral transfer of the yeast from the donor cell to the recipient cell. 
The whole process takes only seven minutes. (J to M) Upon completion, the cryptococcal cell is entirely in the recipient mac-
rophage and the donor macrophage moves away.
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(Improvision), capturing one frame every 90 s for 16 h on
a QICAM camera. The number of lateral transfer event was
counted by eye.
For producing Figure 1 and Additional Files 1 and 2, the
original time-lapse movie was decompiled into individual
TIFF images with ImageJ. These were then cropped to the
region of interest and sharpened. A semiopaque mask and
arrow were added to the first frame (to indicate the cell of
interest) with Adobe Photoshop 7.0 before the TIFF image
stack was recompiled into a QuickTime movie with
ImageJ.
Note added in proof
The publication of this article was coordinated with the
publication of 'Cell-to-cell spread and massive vacuole
formation after Cryptococcus neoformans and infection
of murine macrophages' by Alvarez and Casadevall in
BMC Immunology [18].
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Additional file 1
Lateral transfer of JEC21 from an infected to an uninfected human pri-
mary macrophage. The infected (donor) cell is highlighted in the first 
frame. The donor cell moves underneath the recipient cell and, at 1:25, 
the recipient macrophage contacts the cryptococcal phagosome. About 160 
min after the onset of filming, membrane fusion starts to occur at the con-
tact point of the two cells and initiates lateral transfer of the yeast from 
the donor cell to the recipient cell. The whole process takes only seven min-
utes. Upon completion, the cryptococcal cell is entirely in the recipient 
macrophage and the donor macrophage moves away.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2172-8-15-S1.mov]
Additional file 2
Lateral transfer of Cryptococcus neoformans strain 125.91 between 
J774 murine-derived macrophages. The donor cell (highlighted in frame 
one, upper right) transfers one of the two internalized cryptococci to the 
recipient cell (bottom left). The transferred Cryptococcus is marked by a 
white arrow in frame one. The donor cell moves downwards, contacting 
the recipient macrophage approximately 90 minutes after the onset of 
filming. Transfer occurs approximately 115 minutes into the movie. Note 
that the transferred Cryptococcus then moves underneath a surface-
bound cryptococcal cell (clearly visible at 124 minutes), demonstrating 
that it is held within an intracellular compartment and not simply 
attached to the plasma membrane.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
2172-8-15-S2.mov]Page 5 of 5
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